140.03 -1.47 (-1.04%)
994.1K XNYS Volume
XNYS 17 Apr, 2025 5:30 PM (EDT)
DaVita Inc Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
High Financial Strength
Mid Valuation
Technically Bearish
Falling Comet
These stocks are the ones with good quality and mid-range financial aspects. However, their weak technical aspect reduces the investor's interest.
View Similar
Embed DVM
DaVita Inc Stock Price Analysis
Day Price Range | 140 (LTP) 136.5141.6 LowHigh |
Week Price Range | 140 (LTP) 136.5154.9 LowHigh |
Month Price Range | 140 (LTP) 136.5157.1 LowHigh |
52 Week Price Range | 140 (LTP) 128.7179.6 LowHigh |
DaVita Inc Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
DaVita Inc's Revenue was higher than average estimate 2 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Miss
EPS is expected to reduce by 1.4% in FY25
Consensus Recommendation
10 ANALYST Recommendations
HOLD
The consensus recommendation from 10 analysts for DaVita Inc is HOLD
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get DaVita Inc Stock Analysis
DaVita Inc stock analysis with key metrics, changes, and trends.
DaVita Inc Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $12,815.55 M | 5.56% | positive |
| |
Annual Net Profit | $936.34 M | 35.4% | positive |
| |
Price to Earning Ratio | 11.96 | - | positive |
| |
Stock Price | $140.03 | 9.55% | positive |
| |
Quarterly Revenue | $3,294.68 M | 4.73% | positive |
| |
Quarterly Net profit | $259.33 M | 72.12% | positive |
| |
Debt to Equity Ratio | 99.63 | - | negative |
| |
Return on Equity(ROE) | 159.08 % | 159.08% | positive |
| |
Mutual Fund Holding | 31.72 % | -0.45% | negative |
| |
Promoter Share Holding | 1.28 % | 0.04% | positive |
| |
Interest Coverage Ratio | 4.25 | - | positive |
| |
Institutional Holding | 91.63 % | 0.26% | positive |
|
Loading data..
DaVita Inc - Company Profile
What does DaVita Inc do?

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
DaVita Inc Management structure
All Gross Remunerations are in USD
DaVita Inc Board of directors
All Gross Remunerations are in USD